Stifel Nicolaus Cuts DocGo (NASDAQ:DCGO) Price Target to $5.50

DocGo (NASDAQ:DCGO) had its price target lowered by Stifel Nicolaus from $6.50 to $5.50 in a research note issued to investors on Friday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. Stifel Nicolaus’ price objective would indicate a potential upside of 77.99% from the company’s current price.

DCGO has been the subject of several other reports. Needham & Company LLC dropped their target price on shares of DocGo from $7.00 to $4.00 and set a “buy” rating for the company in a research report on Friday. Deutsche Bank Aktiengesellschaft cut shares of DocGo from a “buy” rating to a “hold” rating and dropped their target price for the company from $5.00 to $2.85 in a research report on Friday. One research analyst has rated the stock with a hold rating and five have issued a buy rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $4.89.

DocGo Trading Down 21.2 %

Shares of NASDAQ:DCGO opened at $3.09 on Friday. The firm has a 50 day moving average of $4.58 and a 200-day moving average of $4.02. The stock has a market capitalization of $315.34 million, a PE ratio of 11.04, a PEG ratio of 14.16 and a beta of 1.00. DocGo has a 12 month low of $2.75 and a 12 month high of $5.68.

Insider Activity at DocGo

In related news, General Counsel Ely D. Tendler sold 23,088 shares of DocGo stock in a transaction that occurred on Monday, December 16th. The shares were sold at an average price of $4.44, for a total transaction of $102,510.72. Following the sale, the general counsel now directly owns 175,645 shares of the company’s stock, valued at approximately $779,863.80. The trade was a 11.62 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 2.70% of the stock is currently owned by insiders.

Institutional Investors Weigh In On DocGo

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Centiva Capital LP bought a new stake in shares of DocGo during the 3rd quarter valued at approximately $43,000. Summit Investment Advisors Inc. grew its holdings in shares of DocGo by 38.7% during the 4th quarter. Summit Investment Advisors Inc. now owns 10,639 shares of the company’s stock valued at $45,000 after purchasing an additional 2,968 shares during the last quarter. Prudential Financial Inc. bought a new stake in shares of DocGo during the 4th quarter valued at approximately $55,000. Intech Investment Management LLC bought a new stake in DocGo during the 3rd quarter worth approximately $62,000. Finally, Royce & Associates LP bought a new stake in DocGo during the 4th quarter worth approximately $64,000. 56.44% of the stock is owned by institutional investors.

DocGo Company Profile

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.